The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation

Seminars in Thrombosis and Hemostasis

Volumn 41, Issue 2, 2015, Pages 133-140

  Prandoni, Paolo ^a   Lensing, Anthonie W A ^b   Prins, Martin H ^c   Pesavento, Raffaele ^a   Piccioli, Andrea ^a   Sartori, Maria T ^a   Tormene, Daniela ^a   Milan, Marta ^a   Vedovetto, Valentina ^a   Noventa, Franco ^a   Villalta, Sabina ^d   Harenberg, Job ^e  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d University Hospital of Treviso   (Italy)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

arterial thrombosis; cancer; deep venous thrombosis; post thrombotic syndrome; residual thrombosis; ultrasonography

Indexed keywords

ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; VITAMIN K GROUP;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; FEMORAL VEIN; FOLLOW UP; HUMAN; INCIDENCE; KIDNEY VEIN THROMBOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; OUTCOME ASSESSMENT; POPLITEAL VEIN; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; RESIDUAL VEIN THROMBOSIS; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; METABOLISM; MORTALITY; NEOPLASMS; POSTTHROMBOTIC SYNDROME; VENOUS THROMBOSIS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POSTTHROMBOTIC SYNDROME; RECURRENCE; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; VITAMIN K;

EID: 84923864676     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1544161     Document Type: Article

References (24)

1. Tan M., Mos I. C., Klok F. A., Huisman M. V. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review. Br J Haematol: 2011; 153 2 168 178
2. Donadini M. P., Ageno W., Antonucci E., et al. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost: 2014; 111 1 172 179
3. Carrier M., Rodger M. A., Wells P. S., Righini M., LE Gal G. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost: 2011; 9 6 1119 1125
4. Kearon C., Akl E. A., Comerota A. J., et al. American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 (2, Suppl): e419S e494S
5. Kahn S. R., Partsch H., Vedantham S., Prandoni P., Kearon C.; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost: 2009; 7 5 879 883
6. Kearon C., Iorio A., Palareti G.; Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost: 2010; 8 10 2313 2315
7. Prandoni P., Bilora F., Marchiori A., et al. An association between atherosclerosis and venous thrombosis. N Engl J Med: 2003; 348 15 1435 1441
8. Becattini C., Vedovati M. C., Ageno W., Dentali F., Agnelli G. Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. J Thromb Haemost: 2010; 8 5 891 897
9. Vandvik P. O., Lincoff A. M., Gore J. M., et al. American College of Chest Physicians. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 (2, Suppl): e637S e668S
10. Prandoni P., Lensing A. WA, Büller H. R., et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med: 1992; 327 16 1128 1133
11. Sorensen H. T., Sværke C., Farkas D. K., et al. Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. Eur J Cancer: 2012; 48 4 586 593
12. Prandoni P., Casiglia E., Piccioli A., et al. The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months. J Thromb Haemost: 2010; 8 5 1126 1127
13. Bouman A. C., Smits J. J., Ten Cate H., Ten Cate-Hoek A. J. Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome. J Thromb Haemost: 2012; 10 8 1532 1538
14. Bakirci E. M., Topcu S., Kalkan K., et al. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. Clin Appl Thromb Hemost: 2013;; [Epub ahead of print]
15. Comerota A. J., Grewal N., Martinez J. T., et al. Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. J Vasc Surg: 2012; 55 3 768 773
16. Aziz F., Comerota A. J. Quantity of residual thrombus after successful catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with recurrence. Eur J Vasc Endovasc Surg: 2012; 44 2 210 213
17. Hirmerova J., Seidlerova J., Filipovsky J. Risk factors for residual thrombotic occlusion after proximal deep vein thrombosis of the legs. Int Angiol: 2010; 29 4 317 322
18. Prandoni P., Lensing A. WA, Prins M. H., et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med: 2002; 137 12 955 960
19. Tan M., Bornais C., Rodger M. Interobserver reliability of compression ultrasound for residual thrombosis after first unprovoked deep vein thrombosis. J Thromb Haemost: 2012; 10 9 1775 1782
20. Palareti G., Cosmi B., Legnani C., et al. DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood: 2014; 124 2 196 203
21. Young L., Ockelford P., Milne D., Rolfe-Vyson V., Mckelvie S., Harper P. Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost: 2006; 4 9 1919 1924
22. Killewich L. A., Macko R. F., Cox K., et al. Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement. J Vasc Surg: 1997; 26 5 861 868
23. Bern M. M., McCarthy N. Failure to lyse venous thrombi because of elevated plasminogen activator Inhibitor 1 (PAI-1) and 4G polymorphism of its promotor genome (The PAI-1/4G Syndrome). Clin Appl Thromb Hemost: 2010; 16 5 574 578
24. Zapponi K. C., Mazetto B. M., Bittar L. F., et al. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels. Thromb Res: 2014; 133 5 736 742